United Orthopedic Corporation (4129)
TWSE
Closed
Oct 7, 2026
Day's Range
83.0052 wk Range
81.00Overview - 4129 - United Orthopedic Corporation
Key Statistics
Valuation
Enterprise Value
9.81B
P/E (Trailing)
‪14.77‬
P/E (Forward)
‪11.65‬
PEG Ratio
‪0.07‬
Price / Sales (TTM)
‪1.30‬
Price / Book
‪2.03‬
EV / EBITDA
‪7.96‬
Profitability
Gross Margin
‪78.47%‬
Profit Margin
‪9.09%‬
Operating Margin
‪12.02%‬
Return on Assets
‪5.55%‬
Return on Equity
‪14.28%‬
Ownership
Shares Outstanding
96.43M
Float
77.38M
Held by Insiders
‪38.99%‬
Held by Institutions
‪2.12%‬
Price stats
Beta
‪0.41‬
50-Day Avg
‪83.91‬
200-Day Avg
‪97.06‬
Dividends
Payout Ratio
‪71.81%‬
Frequency
Annual
Analyst Consensus
4 analysts
Average price target
‪NT$ 123.67‬Market Cap - 4129 - United Orthopedic Corporation
Peers - 4129 - United Orthopedic Corporation
Peer Comparison
Compared with companies in Medical Devices listed on TWSE.
Profile Summary - 4129 - United Orthopedic Corporation
About
United Orthopedic Corporation is a global manufacturer specializing in advanced orthopedic medical devices, primarily focusing on innovative hip and knee replacement implants and surgical instrument sets. Since its founding in 1993 and headquartered in Hsinchu, Taiwan, the company has established itself as a leading…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
